



























                                                      
3 Lactate is then released into the intercellular matrix where, through the Cori Cycle, it is 
transported back to the liver and resynthesized to glucose, at considerable expense of ATP that is 
procured from normal oxidative metabolism in healthy cells.  
4 In addition to glucose metabolism, glutamine metabolism is altered, providing access to needed 







                                                      
5 The control of phosphofructokinase by ATP had been discovered independently as a result of 
discovery of oscillations in the concentrations of NAD+ and other intermediates and 
determination that these oscillations resulted from the feedback of ATP on the mechanism 
(Ghosh and Chance 1964). 
forwards	and	backwards	(Craver	and	Darden	2013)	to	identify	operations	in	the	control	mechanisms.	Researchers	attempted	to	organize	these	operations	into	pathways	characterized	by	sequences	of	reactions	and	then	to	link	these	pathways	to	flexible	constraints	in	primary	mechanisms.	But	this	research	also	reveals	that	these	pathways	interconnect.	Although	Figures	1-3	show	pathways,	they	also	reveal	numerous	points	of	connection.	If	one	follows	these	out,	it	becomes	apparent	that	in	fact	the	control	systems	are	not	independent	but	integrated	into	a	single	network.	In	this	section	I	will	note	a	couple	of	these	points	of	integration	and	then	demonstrate	how	network	analyses	are	now	playing	crucial	roles	in	advancing	the	understanding	of	both	cancer	and	control	in	normal	cells.			Above	I	focused	on	the	roles	mutated	Ras	proteins	play	in	promoting	proliferation,	but	they	also	regulate	many	other	mechanisms	responsible	for	hallmarks	of	cancer.	When	the	signal	they	produce	is	too	strong,	apoptosis	is	induced	by	activating	Rb	and	TP53.	In	addition,	Ras	proteins,	as	well	as	other	oncogenes,	up	regulate	GLUT1	(Murakami	et	al.	1992),	thereby	increasing	glycolysis.	Ras	proteins	also	figure	in	the	key	alternative	pathways	in	glycolysis—in	the	pentose	phosphate	pathway,	they	up	regulate	two	key	enzymes,	transketolase-like	1	(TKTL1)	and	transaldolase	(TALDO).	These	enzymes	are	in	turn	suppressed	by	TP53,	so	when	Ras	proteins	are	sufficiently	active	so	as	to	activate	TP53,	it	down-regulates	these	enzymes.	Thus,	Ras	proteins	are	implicated	in	proliferation,	apoptosis,	and	altered	metabolism.			HIF-1	also	figures	in	control	of	many	cell	mechanisms.	Above	I	only	addressed	the	pathways	on	the	left	side	of	Figure	2	through	which	HIF-1	operates	to	control	glycolysis.	But	the	figure	also	indicates	that	HIF-1	plays	a	role	in	regulating	vascular	endothelial	growth	factor	(VEGF),	which	encodes	ligands	that	control	new	blood	vessel	growth	during	embryonic	and	postnatal	development	and	is	up-regulated	in	hypoxia	and	cancer	(Ferrara	2009).	Thus,	it	also	helps	explain	the	hallmark	of	angiogenesis.	Angiogenesis	is	also	controlled	by	lactate	resulting	from	the	altered	control	HIF-1	exerts	over	glycolysis	in	cancer	cells	(Végran	et	al.	2011).	Finally,	HIF-1	up-regulates	erythropoietin	(EPO),	which	stimulates	production	of	red	blood	cells.	By	controlling	these	two	processes,	HIF-1	functions	to	increase	oxygen	and	nutrient	delivery	beyond	what	is	required	in	normal	cell	function.	This	research	has	revealed	that	HIF-1	performs	control	operations	with	respect	to	a	diverse	range	of	cell	mechanisms.			Yet	another	example	in	which	research	has	pointed	to	the	interaction	of	control	processes	is	provided	by	the	protein	subunit	of	telomeres,	telomere	reverse	transcriptase	(TERT).	In	addition	to	its	role	in	adding	telomeres	and	thus	defeating	the	Hayflick	limit	on	cell	replication,	noted	above,	TERT	also	functions	as	a	cofactor	of	β-catenin/LEF	transcription	factor	complex	that	figures	in	the	Wnt	pathway	(not	discussed	above	but	shown	in	the	upper	left	of	Figure	1).	The	Wnt	pathway	is	important	in	regulating	the	cell	cycle	as	it	activates	replication	in	stem	cells	(Park	et	al.	2009;	Bryja,	Červenka,	and	Čajánek	2017).	TERT	has	also	been	shown	to	have	effects	on	regulating	apoptosis	(Kang	et	al.	2004)	and	DNA-damage	repair	(Masutomi	et	al.	2005).		These	various	findings	illustrate	something	that	is	already	apparent	in	Figure	1:	the	different	pathways	involved	in	control	of	cell	processes	are	not	independent,	but	interact	at	
numerous	points.	Although	the	notion	of	pathway	plays	an	important	role	when	tracing	out	the	individual	steps	in	specific	control	mechanisms,	it	does	not	provide	the	best	way	to	understand	these	interactions.	Conceptualizing	control	in	terms	of	networks	provides	an	alternative	framework	that	is	increasingly	being	employed	in	cancer	research	to	understand	control	systems	that	are	operative	in	both	cancer	and	normal	cells.	Network	diagrams	consist	of	nodes	and	edges,	in	which	nodes	stand	for	various	kinds	of	entities	(genes,	proteins,	etc.)	and	edges	for	various	types	of	interactions	between	nodes.	Pathway	analyses	can	be	transformed	into	network	diagrams	by	abstracting	from	specific	details	(Figure	1	effectively	does	that),	but	there	are	other	strategies	for	constructing	network	models	that	can	yield	additional	insights	into	control	systems.			Researchers	working	on	model	organisms	such	as	yeast	have	created	network	diagrams	based	on	a	variety	of	types	of	gene	and	protein	interaction	data.	For	example,	the	yeast	two-hybrid	technique	reveals	which	proteins	in	a	cell	are	able	to	form	complexes	whereas	investigations	of	synthetic	lethality	indicate	genes	that	interact	in	the	generation	of	traits.	In	Bechtel	(2017,	in	press)	I	have	shown	how	analyses	of	these	networks	have	provided	new	insights	into	the	mechanisms	involved	in	yeast	cells.6	Similar	data	is	now	being	generated	for	human	cells,	but	in	the	meantime	investigators	have	also	found	it	productive	to	predict	gene	and	protein	interactions	on	the	basis	of	homology	between	model	organisms	and	humans.	These	networks	alone	do	not	provide	information	about	where	proteins	are	expressed	in	cells	or	the	biological	processes	to	which	they	contribute,	crucial	for	a	mechanistic	understanding.	However,	network	researchers	have	developed	strategies	for	annotating	these	networks	with	this	type	of	information	using	resources	such	as	Gene	Ontology	(GO)	(Ashburner	et	al.	2000).7			Given	the	number	of	interactions	between	genes	and	proteins	that	these	techniques	reveal,	the	resulting	network	diagrams	initially	appear	as	hairballs	in	which	no	interpretable	patterns	can	be	identified.	Network	researchers	have	developed	a	number	of	analytical	tools,	available	in	network	representation	platforms	such	as	Cytoscape	(Shannon	et	al.	2003),	to	make	sense	of	networks.	A	particularly	useful	type	of	analysis	that	Cytoscape	facilitates	is	identifying	clusters	in	networks—sets	of	nodes	that	are	especially	densely	interconnected.	Network	researchers	often	interpret	dense	clusters	of	highly	interconnected	nodes	in	protein-protein	interaction	networks	as	mechanisms	engaged	in	particular	tasks	whereas	connections	between	these	modules	are	interpreted	as	vehicles	of	control.	Other	tools	in	Cytoscape	that	help	turn	hairballs	into	interpretable	networks	are	layout	algorithms	(such	as	force-based	ones	that	treat	edges	like	springs,	pulling	connected	nodes	situated	far	from	each	other	together	and	pushing	those	very	close	to	each	other	slightly	apart)	and	filtering	tools	to	look	selectively	at	particular	nodes	and	edges.			
                                                      
6 There is disagreement as to whether network analyses complement (Matthiessen 2017) or 
compete with (Braillard 2010) mechanistic accounts. In Green et al. (2018), we discuss a range 
of examples of network analyses, ranging from those that integrate with mechanistic accounts to 
those that abstract from concrete mechanisms to focus on dynamics. 
7 For a philosophical examination of the classification scheme employed in GO, see Leonelli 
(2010). 
I	will	present	one	example	in	which	researchers	extended	a	pathway	analysis	into	a	network	analysis.	From	Reactome,	a	database	of	pathways,	and	a	variety	of	resources	providing	protein	and	gene	interaction	data,	Wu,	Feng,	and	Stein	(2010)	developed	a	large	network	of	10,956	proteins	and	209,988	interactions,	which	they	termed	the	Functional	Interaction	(FI)	network.	They	used	this	network	to	interpret	glioblastoma	data	compiled	in	The	Cancer	Genome	Atlas’s	characterization	of	206	glioblastomas	(Cancer	Genome	Atlas	Research	Network	2008).	The	researchers	identified	those	proteins	in	FI	that	corresponded	to	genes	identified	as	mutated	in	at	least	two	TCGA	samples.	They	then	included	the	fewest	additional	proteins	in	FI	to	create	a	connected	network	including	at	least	70%	of	these	altered	genes.	They	proposed	that	the	resulting	network,	shown	in	Figure	4,	is	the	core	subnetwork	of	mutations	in	glioblastoma.	Since	they	had	begun	with	a	pathway	analysis	from	Reactome,	they	were	able	to	identify	those	proteins	in	their	proposed	core	subnetwork	that	belonged	to	four	pathways—p53,	focal	adhesion,	signaling	by	PDGF,	and		
	Figure	4.	Core	subnetwork	Wu,	Feng,	and	Stein	extracted	from	TCGA	glioblastoma	data	with	identification	of	genes	in	four	pathways	shown	in	shaded	regions.	The	color	of	the	nodes	indicates	genes	shared	in	another	sample	of	glioblastoma	tumors	(yellow)	or	not	shared	(blue).	Red	indicates	those	nodes	added	to	connect	the	network.	Node	size	indicates	frequency	of	mutation	in	TCGA	sample.	This	appears	as	Figure	8A	in	Wu,	Feng,	and	Stein	(2010)	and	is	reprinted	from	BioMed	Central	under	the	Creative	Commons	Attribution	(CC-BY)	license.		
cell	cycle	pathways.	These	are	shown	in	shading	in	Figure	4.	The	figure	reveals	both	that	many	of	the	proteins	in	the	network	belong	to	these	four	pathways	and	also	that	these	pathways	are	highly	intertwined.		Network	analyses	go	beyond	the	pathway	analyses	in	revealing	the	interconnected	nature	of	the	control	mechanisms	operative	in	normal	cells	and	disrupted	in	cancer.	In	particular,	they	provide	a	strategy	to	avoid	thinking	of	control	in	purely	hierarchical	terms,	with	controllers	residing	at	a	higher	level	than	the	processes	they	control.	As	noted	above,	in	human-made	machines,	control	processes	are	organized	hierarchically	to	enable	human	operators	to	determine	the	activity	of	the	machine.	But	in	biological	organisms,	control	mechanisms	generally	terminate	within	the	organism.	Different	components	of	the	organism	initiate	control	processes	that	regulate	other	components,	but	this	does	not	lead	to	a	top-level	controller	overseeing	the	whole	operation.	Instead,	the	research	reveals	a	network	in	which	multiple	control	mechanisms	are	embedded	and	through	which	they	interact.	As	a	result	of	their	interactions,	when	a	gene	is	mutated,	as	in	cancer,	it	does	not	alter	the	behavior	of	just	one	primary	mechanism,	but	often	a	wide	range	(giving	rise	to	the	multiple	hallmarks	of	cancer	discussed	above).		
7.	Conclusions		I	have	presented	a	range	of	examples	of	research	on	cancer	as	a	way	to	make	clear	how	complex	the	control	processes	operating	on	mechanisms	in	living	cells	are.	The	hallmarks	of	cancer	identified	by	Hanahan	and	Weinberg	all	involve	altered	deployments	of	primary	mechanisms	that	figure	in	normal	cell	life.	Altered	deployment	results	from	changes	in	control	mechanisms	that	determine	when	these	various	primary	mechanisms	operate.	These	control	mechanisms	are	productively	analyzed	in	terms	of	pathways	consisting	of	components	that	act	sequentially	on	each	other.	But,	as	I	have	tried	to	illustrate,	these	pathways	often	interact	with	one	another,	constituting	networks.	In	addition	to	the	primary	mechanisms	that	are	responsible	for	phenomena	such	as	energy	procurement	and	protein	synthesis,	cells	contain	complex	networks	of	control	mechanisms	that	operate	on	flexible	constraints	in	the	primary	mechanisms.	Changes	in	control	mechanisms	result	in	the	redeployment	of	the	primary	mechanisms	to	maintain	the	altered	life	of	a	cancer	cell.			Philosophical	accounts	of	biological	mechanisms	have	not	emphasized	control,	instead	treating	mechanisms	as	operating	whenever	their	start-up	conditions	are	realized	(Machamer,	Darden,	and	Craver	2000).	In	this	paper	I	have	advanced	a	perspective	in	which	the	parts	and	operations	of	mechanisms	provide	constraints	that	direct	the	flow	of	free	energy,	enabling	the	mechanism	to	perform	work.	Many	of	the	constraints	in	mechanisms	are	flexible,	capable	of	being	altered	through	work	performed	by	other	mechanisms.	These	other	mechanisms	exercise	control.	They	too	involve	flexible	constraints	that	are	capable	of	being	operated	on	by	yet	other	mechanisms.	In	human-built	machines,	such	a	hierarchy	of	control	mechanisms	typically	tops	out	when	human	agents	alter	constraints	to	exercise	control.	But	in	biological	organisms	control	processes	originate	within	organisms	and	enable	the	primary	mechanisms	they	control	to	operate	appropriately	to	maintain	the	organisms.	Since	these	control	mechanisms	are	interconnected,	it	is	helpful	to	represent	them	in	a	network,	not	a	strict	hierarchy.		
	A	fundamental	lesson	to	be	learned	from	cancer	research	is	that	there	is	a	complex	web	of	control	operative	on	biological	mechanisms.	The	philosophical	analysis	of	mechanisms	needs	to	be	extended	from	focusing	exclusively	on	how	primary	mechanisms	produce	the	phenomenon	for	which	they	are	responsible	to	how	they	are	controlled.	This	involves	identifying	flexible	constraints	and	then	looking	beyond	the	primary	mechanisms	to	the	other	mechanisms	that	operate	on	those	constraints.	This	presents	a	challenging	new	task	for	those	interested	in	mechanistic	explanations	in	biology:	characterizing	how	control	networks	are	organized	in	a	manner	that	primary	mechanisms	produce	their	phenomena	in	ways	appropriate	to	maintaining	an	organism.			
Acknowledgment:	I	thank	Sara	Green	and	Jason	Winning	for	extremely	helpful	comments	on	previous	drafts	of	this	paper	and	discussion	of	topics	discussed	in	it.	I	also	thank	anonymous	reviewers	for	this	journal	for	valuable	suggestions.			
References		Adams,	Jerry	M.,	and	Suzanne	Cory.	(2007).	"The	Bcl-2	Apoptotic	Switch	in	Cancer	Development	and	Therapy."	Oncogene	26:1324-1337.	Ashburner,	Michael,	Catherine	A.	Ball,	Judith	A.	Blake,	David	Botstein,	Heather	Butler,	J.	Michael	Cherry,	Allan	P.	Davis,	Kara	Dolinski,	Selina	S.	Dwight,	Janan	T.	Eppig,	Midori	A.	Harris,	David	P.	Hill,	Laurie	Issel-Tarver,	Andrew	Kasarskis,	Suzanna	Lewis,	John	C.	Matese,	Joel	E.	Richardson,	Martin	Ringwald,	Gerald	M.	Rubin,	and	Gavin	Sherlock.	(2000).	"Gene	Ontology:	Tool	for	the	Unification	of	Biology."	Nature	Genetics	25:25-29.	Bechtel,	William.	(2006).	Discovering	Cell	Mechanisms:	The	Creation	of	Modern	Cell	Biology,	Cambridge:	Cambridge	University	Press.	———.	(2008).	Mental	Mechanisms.	Philosophical	Perspectives	on	Cognitive	Neuroscience,	London:	Routledge.	———.	(2017).	"Using	the	Hierarchy	of	Biological	Ontologies	to	Identify	Mechanisms	in	Flat	Networks."	Biology	&	Philosophy	32:627-649.	———.	(in	press).	"Analyzing	Network	Models	to	Make	Discoveries	About	Biological	Mechanisms."	
British	Journal	for	the	Philosophy	of	Science.	Bechtel,	William,	and	Adele	Abrahamsen.	(2005).	"Explanation:	A	Mechanist	Alternative."	Studies	in	
History	and	Philosophy	of	Biological	and	Biomedical	Sciences	36:421-441.	———.	(2009).	"Decomposing,	Recomposing,	and	Situating	Circadian	Mechanisms:	Three	Tasks	in	Developing	Mechanistic	Explanations,"	In	H.	Leitgeb	and	A.	Hieke,	eds.,	Reduction	and	
Elimination	in	Philosophy	of	Mind	and	Philosophy	of	Neuroscience,	173-186.	Frankfurt:	Ontos	Verlag.	———.	(2010).	"Dynamic	Mechanistic	Explanation:	Computational	Modeling	of	Circadian	Rhythms	as	an	Exemplar	for	Cognitive	Science."	Studies	in	History	and	Philosophy	of	Science	Part	A	41:321-333.	———.	(2013).	"Thinking	Dynamically	About	Biological	Mechanisms:	Networks	of	Coupled	Oscillators."	Foundations	of	Science	18:707-723.	Bechtel,	William,	and	Robert	C.	Richardson.	(1993/2010).	Discovering	Complexity:	Decomposition	
and	Localization	as	Strategies	in	Scientific	Research,	Cambridge,	MA:	MIT	Press.	1993	edition	published	by	Princeton	University	Press.	
Braillard,	Pierre-Alain.	(2010).	"Systems	Biology	and	the	Mechanistic	Framework."	History	and	
philosophy	of	the	life	sciences	32:43-62.	Bryja,	Vítězslav,	Igor	Červenka,	and	Lukáš	Čajánek.	(2017).	"The	Connections	of	Wnt	Pathway	Components	with	Cell	Cycle	and	Centrosome:	Side	Effects	or	a	Hidden	Logic?"	Critical	
Reviews	in	Biochemistry	and	Molecular	Biology:1-24.	Burkhart,	Deborah	L.,	and	Julien	Sage.	(2008).	"Cellular	Mechanisms	of	Tumour	Suppression	by	the	Retinoblastoma	Gene."	Nature	Reviews	Cancer	8:671-682.	Cancer	Genome	Atlas	Research	Network.	(2008).	"Comprehensive	Genomic	Characterization	Defines	Human	Glioblastoma	Genes	and	Core	Pathways."	Nature	455:1061-1068.	Craver,	Carl	F.	(2007).	Explaining	the	Brain:		Mechanisms	and	the	Mosaic	Unity	of	Neuroscience,	New	York:	Oxford	University	Press.	Craver,	Carl	F.,	and	Lindley	Darden.	(2013).	In	Search	of	Mechanisms:	Discoveries	across	the	Life	
Sciences,	Chicago:	University	of	Chicago	Press.	Darden,	Lindley,	and	Carl	Craver.	(2002).	"Strategies	in	the	Interfield	Discovery	of	the	Mechanism	of	Protein	Synthesis."	Studies	in	History	and	Philosophy	of	Biological	and	Biomedical	Sciences	33:1-28.	Ellis,	Ronald	W.,	Deborah	Defeo,	Thomas	Y.	Shih,	Matthew	A.	Gonda,	Howard	A.	Young,	Nubuo	Tsuchida,	Douglas	R.	Lowy,	and	Edward	M.	Scolnick.	(1981).	"The	P21	Src	Genes	of	Harvey	and	Kirsten	Sarcoma	Viruses	Originate	from	Divergent	Members	of	a	Family	of	Normal	Vertebrate	Genes."	Nature	292:506-511.	Feng,	Yuchen,	Ding	He,	Zhiyuan	Yao,	and	Daniel	J.	Klionsky.	(2014).	"The	Machinery	of	Macroautophagy."	Cell	Research	24:24-41.	Ferrara,	Napoleone.	(2009).	"Vascular	Endothelial	Growth	Factor."	Arteriosclerosis,	Thrombosis,	and	
Vascular	Biology	29:789.	Fruton,	Joseph	S.	(1972).	Molecules	and	Life:	Historical	Essays	on	the	Interplay	of	Chemistry	and	
Biology,	New	York:	Wiley	Interscience.	Ghosh,	Amal	K.,	and	Britton	Chance.	(1964).	"Oscillations	of	Glycolytic	Intermediates	in	Yeast	Cells."	
Biochemical	and	Biophysical	Research	Communications	16:174-181.	Green,	Sara,	Maria	Şerban,	Raphael	Scholl,	Nicholaos	Jones,	Ingo	Brigandt,	and	William	Bechtel.	(2018).	"Network	Analyses	in	Systems	Biology:	New	Strategies	for	Dealing	with	Biological	Complexity."	Synthese	195:1751-1777.	Hanahan,	Douglas,	and	Robert	A.	Weinberg.	(2000).	"The	Hallmarks	of	Cancer."	Cell	100:57-70.	———.	(2011).	"Hallmarks	of	Cancer:	The	Next	Generation."	Cell	144:646-674.	Hayflick,	Leonard,	and	Paul	S.	Moorhead.	(1961).	"The	Serial	Cultivation	of	Human	Diploid	Cell	Strains."	Experimental	Cell	Reseach	25:585-621.	Hooker,	Clifford	A.	(2013).	"On	the	Import	of	Constraints	in	Complex	Dynamical	Systems."	
Foundations	of	Science	18:757-780.	Kang,	Hyo	Jung,	Yoon	Sik	Choi,	Seung-Beom	Hong,	Kee-Won	Kim,	Ran-Sook	Woo,	Seok	Joon	Won,	Eun	Ju	Kim,	Hee	Kyung	Jeon,	So-Young	Jo,	Tae	Kook	Kim,	Robert	Bachoo,	Ian	J	Reynolds,	Byoung	Joo	Gwag,	and	Han-Woong	Lee.	(2004).	"Ectopic	Expression	of	the	Catalytic	Subunit	of	Telomerase	Protects	against	Brain	Injury	Resulting	from	Ischemia	and	Nmda-Induced	Neurotoxicity."	Journal	of	Neuroscience	24:1280-1287.	Keijzer,	Fred,	Marc	van	Duijn,	and	Pamela	Lyon.	(2013).	"What	Nervous	Systems	Do:	Early	Evolution,	Input-Output,	and	the	Skin	Brain	Thesis."	Adaptive	Behavior	21:67-85.	Leonelli,	Sabina.	(2010).	"Documenting	the	Emergence	of	Bio-Ontologies:	Or,	Why	Researching	Bioinformatics	Requires	Hpssb."	History	and	Philosophy	of	the	Life	Sciences	32:105-125.	Lowe,	Scott	W.,	Enrique	Cepero,	and	Gerard	Evan.	(2004).	"Intrinsic	Tumour	Suppression."	Nature	432:307-315.	Machamer,	Peter,	Lindley	Darden,	and	Carl	F.	Craver.	(2000).	"Thinking	About	Mechanisms."	
Philosophy	of	Science	67:1-25.	
Masutomi,	Kenkichi,	Richard	Possemato,	Judy	M.	Y.	Wong,	Jennifer	L.	Currier,	Zuzana	Tothova,	Judith	B.	Manola,	Shridar	Ganesan,	Peter	M.	Lansdorp,	Kathleen	Collins,	and	William	C.	Hahn.	(2005).	"The	Telomerase	Reverse	Transcriptase	Regulates	Chromatin	State	and	DNA	Damage	Responses."	Proceedings	of	the	National	Academy	of	Science,	USA	102:8222-8227.	Matthiessen,	Dana.	(2017).	"Mechanistic	Explanation	in	Systems	Biology:	Cellular	Networks."	The	
British	Journal	for	the	Philosophy	of	Science	68:25.	Mizushima,	Noboru.	(2007).	"Autophagy:	Process	and	Function."	Genes	and	Development	21:2861-2873.	Moreno,	Alvaro,	and	Matteo	Mossio.	(2015).	Biological	Autonomy:	A	Philosophical	and	Theoretical	
Inquiry,	Dordrecht:	Springer.	Murakami,	Takashi,	Toshihiko	Nishiyama,	Tetsuya	Shirotani,	Yasuo	Shinohara,	Masshara	Kan,	Kazuo	Ishii,	Fumihiko	Kanai,	Shiochi	Nakazuru,	and	Yousuke	Ebina.	(1992).	"Identification	of	Two	Enhancer	Elements	in	the	Gene	Encoding	the	Type	1	Glucose	Transporter	from	the	Mouse	Which	Are	Responsive	to	Serum,	Growth	Factor,	and	Oncogenes."	Journal	of	
Biological	Chemistry	267:9300-9306.	Murphree,	A.	Linn,	and	William	F.	Benedict.	(1984).	"Retinoblastoma:	Clues	to	Human	Oncogenesis."	Science	223:1028-1033.	Needham,	Dorothy	M.	(1971).	Machina	Carnis:		The	Biochemistry	of	Muscular	Contraction	in	Its	
Historical	Development,	Cambridge:	Cambridge	University	Press.	Park,	Jae-Il,	Andrew	S.	Venteicher,	Ji	Yeon	Hong,	Jinkuk	Choi,	Sohee	Jun,	Marina	Shkreli,	Woody	Chang,	Zhaojing	Meng,	Peggie	Cheung,	Hong	Ji,	Margaret	McLaughlin,	Timothy	D.	Veenstra,	Roel	Nusse,	Pierre	D.	McCrea,	and	Steven	E.	Artandi.	(2009).	"Telomerase	Modulates	Wnt	Signalling	by	Association	with	Target	Gene	Chromatin."	Nature	460:66-U77.	Pattee,	Howard	Hunt,	and	Joanna	Rączaszek-Leonardi.	(2012).	Laws,	Language	and	Life.	Howard	
Pattee's	Classic	Papers	on	the	Physics	of	Symbols	with	Contemporary	Commentary	by	Howard	
Pattee	and	Joanna	Raczaszek-Leonardi,	Dordrecht:	Springer.	Pavlova,	Natalya	N,	and	Craig	B	Thompson.	(2016).	"The	Emerging	Hallmarks	of	Cancer	Metabolism."	Cell	Metabolism	23:27-47.	Potter,	Van	Rensselaer.	(1958).	"The	Biochemical	Approach	to	the	Cancer	Problem."	Fed	Proc	17:691-697.	Semenza,	Gregg	L.	(2010).	"Hif-1:	Upstream	and	Downstream	of	Cancer	Metabolism."	Current	
Opinion	in	Genetics	&	Development	20:51-56.	Shannon,	Paul,	Andrew	Markiel,	Owen	Ozier,	Nitin	S.	Baliga,	Jonathan	T.	Wang,	Daniel	Ramage,	Nada	Amin,	Benno	Schwikowski,	and	Trey	Ideker.	(2003).	"Cytoscape:	A	Software	Environment	for	Integrated	Models	of	Biomolecular	Interaction	Networks."	Genome	Research	13:2498-2504.	Vander	Heiden,	M.	G.,	L.	C.	Cantley,	and	C.	B.	Thompson.	(2009).	"Understanding	the	Warburg	Effect:	The	Metabolic	Requirements	of	Cell	Proliferation."	Science	324:1029-1033.	Végran,	Frédérique,	Romain	Boidot,	Carine	Michiels,	Pierre	Sonveaux,	and	Olivier	Feron.	(2011).	"Lactate	Influx	through	the	Endothelial	Cell	Monocarboxylate	Transporter	Mct1	Supports	an	Nf-Κb/Il-8	Pathway	That	Drives	Tumor	Angiogenesis."	Cancer	Research	71:2550.	Vetter,	Ingrid	R.,	and	Alfred	Wittinghofer.	(2001).	"The	Guanine	Nucleotide-Binding	Switch	in	Three	Dimensions."	Science	294:1299-1304.	Warburg,	Otto	Heinrich.	(1930).	The	Metabolism	of	Tumours,	London:	Constable.	———.	(1956).	"On	Respiratory	Impairment	in	Cancer	Cells."	Science	124:269-270.	White,	Eileen,	and	Robert	S.	DiPaola.	(2009).	"The	Double-Edged	Sword	of	Autophagy	Modulation	in	Cancer."	Clinical	Cancer	Research	15:5308-5316.	White,	Eileen,	Cristina	Karp,	Anne	M.	Strohecker,	Yanxiang	X.	Guo,	and	Robin	Mathew.	(2010).	"Role	of	Autophagy	in	Suppression	of	Inflammation	and	Cancer."	Current	Opinion	in	Cell	Biology	22:212-217.	
Willis,	Simon	N.,	and	Jerry	M.	Adams.	(2005).	"Life	in	the	Balance:	How	Bh3-Only	Proteins	Induce	Apoptosis."	Current	Opinion	in	Cell	Biology	17:617-625.	Wu,	Guanming,	Xin	Feng,	and	Lincoln	Stein.	(2010).	"A	Human	Functional	Protein	Interaction	Network	and	Its	Application	to	Cancer	Data	Analysis."	Genome	Biology	11:R53.		
